Certified Adviser
FNCA Sweden AB
Box 5807
102 48 Stockholm
+46 (0)8-528 00 399
info@fnca.se
NASDAQ First North PREMIER Growth Market
Sprint Bioscience stock is traded on Nasdaq First North Premier Growth Market under the name SPRINT.
| Owner | Number of shares | Ownership % |
|---|---|---|
| First Venture | 5 140 732* | 12.9% |
| Nordnet pensionsförsäkring | 4 457 148 | 11.2% |
| Ivar Nordqvist | 3 973 915 | 10.0% |
| Avanza Pension | 2 738 764 | 6.9% |
| Håkan Roos | 1 374 829 | 3.5% |
| Formue Nord | 1 169 242 | 2.9% |
| Mats Westinius/WTS Invest | 921 000 | 2.3% |
| Staffan Halldin | 680 000 | 1.7% |
| Pär Nordlund | 638 085 | 1.6% |
| Jan Löngårdh | 537 133 | 1.3% |
| Oliver Aleksov | 526 501 | 1.3% |
| Dragan Vergic | 473 067 | 1.2% |
| Björn Sjöstrand | 441 177 | 1.1% |
| Kudu VP AB | 424 313 | 1.1% |
| Jessica Martinsson | 267 750 | 0.7% |
| Others | 16 080 393 | 59.6% |
| Total number of shares | 39 844 049 | 100.0% |
*Refers to First Venture (former Första Entreprenörsfonden) and Första Entreprenörsfonden i Norden AB’s total ownership, which is divided into nine companies
